Stem Cells from Skin Fibroblasts in Patients with Hereditary Peripheral Neuropathy

Overview

About this study

This research is being done to develop stem cells from cells within patients’ skin. These stem cells from patients will be used to better understand peripheral neuropathy and help develop treatments.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria

  • Adult patients with clinically documented peripheral neuropathy as determined by a Mayo Clinic Neurologist

  • Adult patients with either a known genetic mutation causative for the peripheral neuropathy or a documented family history of peripheral neuropathy

  • Adult biological family members of affected patient

Exclusion Criteria

  • Adult patients with peripheral neuropathy caused by other etiologies in the estimation of the Mayo Clinic Neurologist without a hereditary component

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nathan Staff, M.D., Ph.D.

Open for enrollment

Contact information:

Michelle Turner

(507)284-1223

Turner.Michelle@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20319883

Mayo Clinic Footer